e-learning
resources
Monograph
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
VAP prevention: pharmacological strategies
L.E. Morrow, M.H. Kollef
Source:
Eur Respir Monogr 2011; 53: 74-82
Journal Issue:
Nosocomial and Ventilator-Associated Pneumonia
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L.E. Morrow, M.H. Kollef. VAP prevention: pharmacological strategies. Eur Respir Monogr 2011; 53: 74-82
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Nosocomial pneumonia: treatment and prevention
Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis
Year: 2004
Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia
Source: ERS Course 2018 - Respiratory Infections
Year: 2018
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
Source: Eur Respir J 2011; 37: 1332-1339
Year: 2011
Implementation of evidence based strategies for prevention of ventilator-associated pneumonia
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008
Evidence on measures for the prevention of ventilator-associated pneumonia
Source: Eur Respir J 2007; 30: 1193-1207
Year: 2007
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017
Year: 2017
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Guideline 2017
Year: 2017
Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia
Source: Annual Congress 2007 - Infections year in review
Year: 2007
Prevention of nosocomial infections in acute respiratory failure patients
Source: Eur Respir J 2003; 22: 72S-76S
Year: 2003
Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Update on preventing and managing hospital-acquired and ventilatory-associated pneumonia
Source: International Congress 2019 – State of the art session: Respiratory infections
Year: 2019
Update on therapeutic strategies in community-acquired pneumonia
Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice
Year: 2017
How to prevent ventilator-associated pneumonia
Source: Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies
Year: 2013
Preventing ventilator-associated pneumonia
Source: International Congress 2017 – PG12 Life-threatening pulmonary infections
Year: 2017
Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 45-49
Year: 2007
Ventilator-associated pneumonia (VAP): epidemiology, empirical treatment and outcome
Source: Eur Respir J 2005; 26: Suppl. 49, 188s
Year: 2005
Impact of guidelines on HAP and VAP outcomes
Source: Eur Respir Mon 2011; 53: 66-73
Year: 2011
Antibiotic treatment for nosocomial pneumonia
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=211
Year: 2004
Prevention of ventilator-associated pneumonia: possible role of antimicrobials administered via the respiratory tract
Source: Eur Respir J 2008; 31: 1138-1139
Year: 2008
Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
Source: Eur Respir J 2007; 30: 307-313
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept